The bill amends South Dakota's controlled substances schedule by adding a comprehensive list of opium derivatives, opiates, and hallucinogenic substances to Schedule I. This includes specific compounds such as acetylcodone, desomorphine, and various fentanyl analogs, as well as hallucinogens like bufotenine, DMT, and LSD. The legislation specifies that any substituted derivatives of fentanyl are included unless they are specifically excepted, listed in another schedule, or contained within an FDA-approved pharmaceutical product. Additionally, the definitions and classifications of certain hallucinogenic substances are modified to ensure that any material or compound containing these substances is classified under Schedule I unless exempted.

The bill also introduces new legal language that details the chemical structures and potential substituents for specific compounds containing indole and carboxamide structures, including various alkyl, haloalkyl, and aromatic groups. It includes a list of trade names associated with synthetic drugs that may pose risks to public health and safety. To address the urgent need for these modifications, the bill declares an emergency, allowing the changes to take effect immediately upon passage and approval, reflecting the necessity to protect the community from the dangers posed by these newly identified substances.

Statutes affected:
Introduced, 01/03/2025: 34-20B-13, 34-20B-14
Enrolled, 02/07/2025: 34-20B-13, 34-20B-14